| # | Drug | Count |
|---|---|---|
| 0 | LAMOTRIGINE | 70 |
| 1 | VENLAFAXINE HYDROCHLORIDE | 69 |
| 2 | LAMOTIRIGINE | 66 |
| 3 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 66 |
| 4 | LAMOTRIGINE EXTENDED-RELEASE | 66 |
| 5 | VENLAFAXINE | 65 |
| 6 | QUETIAPINE | 60 |
| 7 | SERTRALINE | 54 |
| 8 | LEVETIRACETAM | 42 |
| 9 | LEVETIRACETAM IN SODIUM CHLORIDE | 41 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PORACTANT ALFA | 30 | 0.0407 |
| 1 | IBUPROFEN LYSINE | 9 | 0.0158 |
| 2 | CYCLOPENTOLATE HYDROCHLORIDE AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0145 |
| 3 | NIRSEVIMAB | 23 | 0.0128 |
| 4 | CAFFEINE CITRATE | 16 | 0.0069 |
| 5 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 6 | 0.0065 |
| 6 | PHENOBARBITAL SODIUM | 2 | 0.0048 |
| 7 | ALPROSTADIL | 16 | 0.0044 |
| 8 | NALBUPHINE HYDROCHLORIDE | 1 | 0.0044 |
| 9 | METHYLDOPA | 21 | 0.0043 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 89 |
| 1 | Anti-epileptic Agent [EPC] | 84 |
| 2 | Benzodiazepine [EPC] | 79 |
| 3 | Mood Stabilizer [EPC] | 74 |
| 4 | Corticosteroid [EPC] | 39 |
| 5 | Serotonin Reuptake Inhibitor [EPC] | 34 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 33 |
| 7 | Insulin Analog [EPC] | 30 |
| 8 | Surfactant [EPC] | 30 |
| 9 | Vitamin C [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 30 | 0.0258 |
| 1 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 23 | 0.0128 |
| 2 | Oxytocic [EPC] | 9 | 0.0030 |
| 3 | Blood Viscosity Reducer [EPC] | 8 | 0.0018 |
| 4 | Lipid Emulsion [EPC] | 3 | 0.0011 |
| 5 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 5 | 0.0007 |
| 6 | Vitamin K [EPC] | 5 | 0.0006 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 7 | 0.0005 |
| 8 | Human Immunoglobulin G [EPC] | 8 | 0.0004 |
| 9 | Anti-epileptic Agent [EPC] | 84 | 0.0004 |